High Energy Physics - Phenomenology
[Submitted on 28 Apr 2023]
Title:A contact interaction model for the $η$ and $η'$ mesons in a SDE-BSE approach to QCD: masses, decay widths and transition form factors
View PDFAbstract:We construct a contact interaction model for the $\eta$ and $\eta'$ mesons in the SDE-BSE approach to QCD and compute several static properties of these mesons and their transition form factors. We find that this model gives an excellent description of the $\eta$ and $\eta'$ static properties, namely their masses, decay width and decay constants. However, a contact interaction disagrees with experimental data for $Q^2$ greater than 2 GeV$^2$, and produces transition form factors in conflict with perturbative QCD prediction. This is not surpring and the reasons for this are explained
Submission history
From: Jesus Javier Cobos-Martinez [view email][v1] Fri, 28 Apr 2023 14:49:21 UTC (32 KB)
References & Citations
Bibliographic and Citation Tools
Bibliographic Explorer (What is the Explorer?)
Litmaps (What is Litmaps?)
scite Smart Citations (What are Smart Citations?)
Code, Data and Media Associated with this Article
CatalyzeX Code Finder for Papers (What is CatalyzeX?)
DagsHub (What is DagsHub?)
Gotit.pub (What is GotitPub?)
Papers with Code (What is Papers with Code?)
ScienceCast (What is ScienceCast?)
Demos
Recommenders and Search Tools
Influence Flower (What are Influence Flowers?)
Connected Papers (What is Connected Papers?)
CORE Recommender (What is CORE?)
IArxiv Recommender
(What is IArxiv?)
arXivLabs: experimental projects with community collaborators
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.